Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 4
Azacytidine (Vidaza®) in the treatment of myelodysplastic syndromes
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,758 | Dovepress* | 8,758+ | 1,978 | 10,736 | |
| Totals | 8,758 | 1,978 | 10,736 | ||
|
*Since 15 December 2006 +Since July 2016 |
|||||
View citations on Google Scholar